Perma-Fix Achieves Successful Scale-up of Mo-99 Technology

Perma-Fix Medical SA has achieved a successful scale-up of its process to produce Technetium-99m, the company announced yesterday. Earlier this year, Perma-Fix said that it needed to re-configure its production process after realizing the market demand for the medical isotope used in millions of procedures annually called for a larger design. According to the company, the new scaled-up version withstood high levels of radiation, up to 2 curies, while still producing usable doses of Tc-99m. “Achieving these results at higher radiation levels is an important milestone for the company,” Perma-Fix CEO Lou Centofanti said in a statement. “At the 2 curie level, we now meet the industry requirements in many emerging markets that are in need of a decentralized and stable supply chain.  Moreover, we are moving forward with additional demonstrations, which we believe will reinforce the strength of our groundbreaking technology at even higher radiation levels in order to accommodate North American and European customer preferences.”